Risk factors for bacteraemia attributable to Pseudomonas aeruginosa resistant to imipenem, levofloxacin, or gentamicin

被引:7
作者
Mikura, S. [1 ]
Wada, H. [1 ]
Okazaki, M. [2 ]
Nakamura, M. [1 ]
Honda, K. [1 ]
Yasutake, T. [1 ]
Higaki, M. [1 ]
Ishii, H. [1 ]
Watanabe, T. [2 ]
Tsunoda, T. [3 ]
Goto, H. [1 ]
机构
[1] Kyorin Univ, Sch Med, Dept Resp Med, Tokyo 1818611, Japan
[2] Kyorin Univ, Sch Med, Dept Lab Med, Tokyo 1818611, Japan
[3] Kyorin Univ, Sch Med, Dept Prevent Med & Publ Hlth, Tokyo 1818611, Japan
关键词
Antibiotic resistance; Gentamicin; Imipenem; Levofloxacin; Pseudomonas aeruginosa; OUTBREAK;
D O I
10.1016/j.jhin.2011.07.003
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
We studied the risk factors associated with resistance to imipenem, levofloxacin and gentamicin in Pseudomonas aeruginosa isolated from blood cultures of 175 patients in a hospital in Japan. Imipenem resistance was associated with transfer from another hospital, and receiving antifungal medication. Gentamicin resistance was associated with previous administration of a penicillin. No specific risk factors were associated with levofloxacin resistance. (C) 2011 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:267 / 268
页数:2
相关论文
共 8 条
[1]   Risk factor assessment for the acquisition of fluoroquinolone-resistant isolates of Pseudomonas aeruginosa in a community-based hospital [J].
Baddour, LM ;
Hicks, DV ;
Tayidi, MM ;
Roberts, SK ;
Walker, E ;
Smith, RJ ;
Sweitzer, DS ;
Herrington, JA ;
Painter, BG .
MICROBIAL DRUG RESISTANCE-MECHANISMS EPIDEMIOLOGY AND DISEASE, 1995, 1 (03) :219-222
[2]   Fluoroquinolone-resistant Pseudomonas aeruginosa:: Assessment of risk factors and clinical impact [J].
Gasink, Leanne B. ;
Fishman, Neil O. ;
Weiner, Mark G. ;
Nachamkin, Irving ;
Bilker, Warren B. ;
Lautenbach, Ebbing .
AMERICAN JOURNAL OF MEDICINE, 2006, 119 (06) :526.e19-526.e25
[3]   Risk factors for imipenem-resistant Pseudomonas aeruginosa among hospitalized patients [J].
Harris, AD ;
Smith, D ;
Johnson, JA ;
Bradham, DD ;
Roghmann, MC .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (03) :340-345
[4]   Contaminated oral intubation equipment associated with an outbreak of carbapenem-resistant pseudomonas in an intensive care unit [J].
Kikuchi, T. ;
Nagashima, G. ;
Taguchi, K. ;
Kuraishi, H. ;
Nemoto, H. ;
Yamanaka, M. ;
Kawano, R. ;
Ugajin, K. ;
Tazawa, S. ;
Marumo, K. .
JOURNAL OF HOSPITAL INFECTION, 2007, 65 (01) :54-57
[5]   Imipenem resistance among Pseudomonas aeruginosa isolates:: Risk factors for infection and impact of resistance on clinical and economic outcomes [J].
Lautenbach, Ebbing ;
Weiner, Mark G. ;
Nachamkin, Irving ;
Bilker, Warren B. ;
Sheridan, Angela ;
Fishman, Neil O. .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2006, 27 (09) :893-900
[6]  
Satoh Ritsuko, 2008, Journal of Infection and Chemotherapy, V14, P325, DOI 10.1007/s10156-008-0620-5
[7]   Outbreaks of multidrug-resistant Pseudomonas aeruginosa in community hospitals in Japan [J].
Sekiguchi, Jun-Ichiro ;
Asagi, Tsukasa ;
Miyoshi-Akiyama, Tohru ;
Kasai, Atsushi ;
Mizuguchi, Yukie ;
Araake, Minako ;
Fujino, Tornoko ;
Kikuchi, Hideko ;
Sasaki, Satoru ;
Watari, Hajime ;
Kojima, Tadashi ;
Miki, Hiroshi ;
Kanemitsu, Keiji ;
Kunishima, Hiroyuki ;
Kikuchi, Yoshihiro ;
Kaku, Mitsuo ;
Yoshikura, Hiroshi ;
Kuratsuji, Tadatoshi ;
Kirikae, Teruo .
JOURNAL OF CLINICAL MICROBIOLOGY, 2007, 45 (03) :979-989
[8]   Imipenem-resistant Pseudomonas aeruginosa: Risk factors and antibiotic susceptibility patterns [J].
Troillet, N ;
Samore, MH ;
Carmeli, Y .
CLINICAL INFECTIOUS DISEASES, 1997, 25 (05) :1094-1098